Context Therapeutics
CNTX
CNTX
24 hedge funds and large institutions have $2.55M invested in Context Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.
Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
QC
26
Quadrature Capital
London,
United Kingdom
| – | – | -45,889 | Closed |
|
27
Morgan Stanley
New York
| – | – | -17,057 | Closed |
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -14,137 | Closed |
|
29
Two Sigma Advisers
New York
| – | – | -13,400 | Closed |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -100 | Closed |
|
|
CFGS
31
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
RG
32
Retirement Group
San Diego,
California
| $0 | 155 | – | – |
|